Priscilla Merriam

2.1k total citations
28 papers, 1.2k citations indexed

About

Priscilla Merriam is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Priscilla Merriam has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Priscilla Merriam's work include Sarcoma Diagnosis and Treatment (15 papers), Vascular Tumors and Angiosarcomas (9 papers) and Lymphoma Diagnosis and Treatment (6 papers). Priscilla Merriam is often cited by papers focused on Sarcoma Diagnosis and Treatment (15 papers), Vascular Tumors and Angiosarcomas (9 papers) and Lymphoma Diagnosis and Treatment (6 papers). Priscilla Merriam collaborates with scholars based in United States, United Kingdom and Spain. Priscilla Merriam's co-authors include George D. Demetri, Robert G. Maki, David C. Harmon, Suzanne George, Jeffrey A. Morgan, Andrew J. Wagner, Jorge J. Castillo, Naushaba Khan, José Jimeno and Jeffrey T. Yap and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Priscilla Merriam

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Priscilla Merriam United States 13 833 686 252 170 154 28 1.2k
Robin Young United Kingdom 13 719 0.9× 876 1.3× 584 2.3× 55 0.3× 117 0.8× 18 1.1k
Sarah Dumont France 16 386 0.5× 309 0.5× 87 0.3× 194 1.1× 158 1.0× 64 783
Daniela Katz Israel 12 365 0.4× 323 0.5× 161 0.6× 74 0.4× 72 0.5× 29 620
Jean Elwing United States 12 795 1.0× 295 0.4× 311 1.2× 75 0.4× 348 2.3× 60 1.5k
Siddharth Laskar India 17 359 0.4× 236 0.3× 101 0.4× 142 0.8× 175 1.1× 65 871
Marie‐Pierre Sunyach France 15 541 0.6× 299 0.4× 103 0.4× 120 0.7× 133 0.9× 58 858
Bryan Lin United States 14 173 0.2× 298 0.4× 114 0.5× 100 0.6× 256 1.7× 25 1000
Luisa Toffolatti Italy 18 653 0.8× 278 0.4× 73 0.3× 144 0.8× 230 1.5× 42 1.1k
Jenny Potratz Germany 13 351 0.4× 220 0.3× 58 0.2× 66 0.4× 258 1.7× 26 690
Thomas Brodowicz Austria 15 264 0.3× 242 0.4× 50 0.2× 92 0.5× 83 0.5× 32 577

Countries citing papers authored by Priscilla Merriam

Since Specialization
Citations

This map shows the geographic impact of Priscilla Merriam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priscilla Merriam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priscilla Merriam more than expected).

Fields of papers citing papers by Priscilla Merriam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priscilla Merriam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priscilla Merriam. The network helps show where Priscilla Merriam may publish in the future.

Co-authorship network of co-authors of Priscilla Merriam

This figure shows the co-authorship network connecting the top 25 collaborators of Priscilla Merriam. A scholar is included among the top collaborators of Priscilla Merriam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priscilla Merriam. Priscilla Merriam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coté, Gregory M., Candace L. Haddox, Edwin Choy, et al.. (2024). Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma. Clinical Cancer Research. 30(13). 2702–2708. 3 indexed citations
2.
Haddox, Candace L., Michael J. Nathenson, Emanuele Mazzola, et al.. (2024). Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates. Clinical Cancer Research. 30(7). 1281–1292. 17 indexed citations
3.
Bhagavatula, Sharath K., et al.. (2024). Image-guided percutaneous ablation of hepatic epithelioid hemangioendothelioma. Abdominal Radiology. 49(4). 1241–1247. 5 indexed citations
4.
Shulman, David S., Priscilla Merriam, Edwin Choy, et al.. (2023). Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma. Cancer Medicine. 12(14). 15207–15216. 21 indexed citations
5.
Movva, Sujana, Elizabeth A. Handorf, Edwin Choy, et al.. (2023). SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS). Clinical Cancer Research. 30(2). 315–322. 14 indexed citations
6.
McKean, Meredith, Ecaterina E. Dumbrava, Omid Hamid, et al.. (2023). 1021MO Safety and efficacy of etigilimab (anti-TIGIT) with nivolumab (anti-PD1) in recurrent/advanced solid tumors. Annals of Oncology. 34. S621–S622. 3 indexed citations
7.
Shulman, David S., Priscilla Merriam, Edwin Choy, et al.. (2022). Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma.. Journal of Clinical Oncology. 40(16_suppl). e23507–e23507. 3 indexed citations
8.
McKean, Meredith, Ecaterina E. Dumbrava, Omid Hamid, et al.. (2022). Safety and efficacy of etigilimab in combination with nivolumab in select recurrent/advanced solid tumors.. Journal of Clinical Oncology. 40(16_suppl). 2651–2651. 2 indexed citations
9.
Merriam, Priscilla & Michael J. Nathenson. (2021). Liver transplantation for hepatic epithelioid hemangioendothelioma. Cancer. 127(20). 3714–3716. 9 indexed citations
10.
Gounder, Mrinal M., Priscilla Merriam, Ravin Ratan, et al.. (2020). Real‐world outcomes of patients with locally advanced or metastatic epithelioid sarcoma. Cancer. 127(8). 1311–1317. 12 indexed citations
11.
Painter, Corrie, Esha Jain, Brett N. Tomson, et al.. (2020). The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nature Medicine. 26(2). 181–187. 187 indexed citations
12.
Gounder, Mrinal M., Priscilla Merriam, Ravin Ratan, et al.. (2019). Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma. Annals of Oncology. 30. v692–v692. 2 indexed citations
13.
Coté, Gregory M., Edwin Choy, Tianqi Chen, et al.. (2019). A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomas. European Journal of Cancer. 126. 21–32. 16 indexed citations
14.
Schuetze, Scott M., Robert G. Maki, Robin L. Jones, et al.. (2017). Efficacy and safety of patients treated long-term with trabectedin (t) on the expanded access program: A retrospective analysis. Annals of Oncology. 28. v529–v529. 3 indexed citations
15.
George, Suzanne, Constance M. Barysauskas, Sarah Solomon, et al.. (2016). Phase 2 study of nivolumab in metastatic leiomyosarcoma of the uterus.. Journal of Clinical Oncology. 34(15_suppl). 11007–11007. 13 indexed citations
16.
Merriam, Priscilla, et al.. (2014). The relation between cigarette smoking and risk of acute myeloid leukemia: An updated meta‐analysis of epidemiological studies. American Journal of Hematology. 89(8). 83 indexed citations
17.
George, Suzanne, Priscilla Merriam, Robert G. Maki, et al.. (2009). Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor Sarcomas. Journal of Clinical Oncology. 27(19). 3154–3160. 249 indexed citations
18.
García‐Carbonero, Rocio, Judith Manola, Michael V. Seiden, et al.. (2004). Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy. Journal of Clinical Oncology. 22(8). 1480–1490. 250 indexed citations
19.
Ryan, David P., Thomas A. Puchalski, Jeffrey G. Supko, et al.. (2002). A Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients with Gastrointestinal Stromal Tumors. The Oncologist. 7(6). 531–538. 40 indexed citations
20.
Zachariou, Venetia, Dan Georgescu, Leena Kansal, Priscilla Merriam, & Marina R. Picciotto. (2001). Galanin receptor 1 gene expression is regulated by cyclic AMP through a CREB‐dependent mechanism. Journal of Neurochemistry. 76(1). 191–200. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robin Young Breakdown of academic impact, for papers by Sarah Dumont Breakdown of academic impact, for papers by Daniela Katz Breakdown of academic impact, for papers by Jean Elwing Breakdown of academic impact, for papers by Siddharth Laskar Breakdown of academic impact, for papers by Marie‐Pierre Sunyach Breakdown of academic impact, for papers by Bryan Lin Breakdown of academic impact, for papers by Luisa Toffolatti Breakdown of academic impact, for papers by Jenny Potratz Breakdown of academic impact, for papers by Thomas Brodowicz
Rankless by CCL
2026